2011, Number 2
PDF size: 146.65 Kb.
ABSTRACTProstate biopsy is the only procedure for establishing prostate cancer diagnosis. It is considered to be safe and is frequently performed as an out-patient procedure in the physician’s office. However, it presents with a complication rate that should not be ignored.
Methods: An analytical cross-sectional study was carried out that included one hundred seventeen patients with clinical suspicion of prostate cancer who underwent transrectal biopsy of the prostate. Telephone interviews to obtain information about complications were carried out four weeks after procedure had been performed.
Results: A total of 71.8% of patients presented with macroscopic hematuria with mean duration of 2.74 ± 2.3 days and 33.3% of patients presented with rectal bleeding with mean duration of 1.62 ± 1.2 days. A total of 10.3% of patients presented with hematospermia, 5.1% of patients presented with episode of acute urine retention, 6% presented with fever, and 6.8% presented with lower urinary tract obstruction symptomatology. A total of 1.8% of patients presented with dizziness and diaphoresis.
Discussion: Complication frequency, especially of infectious complications, was low due to antibiotic prophylaxis managed in those patients, a fact that was correlated by studies of other authors.
Conclusions: Transrectal prostate biopsy is not innocuous and therefore it is necessary to evaluate the most frequent complications, both major and minor, of this procedure.
Ashby EC, Rees M, Dowding CH. Prophylaxis against systemic infection after transrectal biopsy for suspected prostatic carcinoma. Br Med J 1978;2:1263-4. Vallancien G, Prapotnich D, Veillon B. et al. Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol 1991;146:1308-12.